Results 61 to 70 of about 157,845 (310)

Croatian demographic losses in 20th century [PDF]

open access: yes, 2018
Rad se bavi hrvatskim demografskim gubicima u 20. stoljeću. Analizirani su svi ratovi u kojima je Hrvatska sudjelovala te današnje stanje. Navedene su i moguće revitalizacijske mjere kojima bi se Hrvatska mogla izvući iz demografske krize u kojoj se ...
Lovin Mrak, Josip
core   +2 more sources

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

Hrvatska 2015

open access: yesHrvatska i komparativna javna uprava, 2016
U 2015. dolazi do postupnog gospodarskog oporavka što najavljuje izlazak iz šestogodišnje ekonomske recesije. To je zadnja godina mandata vlade lijevog centra predvođene Socijaldemokratskom partijom (SDP) pa je javni diskurs obilježen žučnim javnim debatama. Za razliku od 2014. i nesuglasica oko primjene europskog uhidbenog naloga, u 2015.
Koprić, Ivan, Škarica, Mihovil
openaire   +1 more source

Prescribing variation across Europe: Insights into prescribing practices and educational needs

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing medication is a complex process, influenced by many factors that can be weighed differently. Four prescriber profiles have been identified: pragmatic‐contextual, guideline‐oriented, experience‐driven and vulnerability‐focused. However, the extent to which European prescribers identify with these profiles and the role of these profiles ...
Mariëlle G. Hartjes   +3 more
wiley   +1 more source

Hrvatska povijest na stranicama Politikina zabavnika [PDF]

open access: yes, 2009
Rad govori o različitim temama iz hrvatske istorije o kojima je između 1952. i 1991. pisao Politikin zabavnik.
Zoran Janjetović
core   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

Međunarodni ugovori pomorskoga prava i prava mora koji obvezuju Republiku Hrvatsku

open access: yesUporedno pomorsko pravo, 1993
Republika Hrvatska kao pomorska država s pozornošću pristupa stvaranju suvremenoga pomorskog zakonodavstva, posebice obvezivanju međunarodnim unifikacijskim instrumentima.
Marina Vokić Žužul
doaj  

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy